IBANDRONIC ACID ACCORD
3MG INJ SOL 1X3ML+1J
Announcement of launch, break or close-out of marketing of a medicinal product
| Type of announcement | Effective date | Alternate medicines ? | Reason for interruption/cessation of marketing | Estimated renewal date |
|---|---|---|---|---|
| Interruption of marketing | 01.07.2022 |
0026099 |
Manufacturing reasons | 01.09.2022 |
| Resumption of marketing | 01.06.2020 | |||
| Interruption of marketing | 21.02.2020 |
0026099 |
Manufacturing reasons | 01.06.2020 |
| Placing on the market | 07.10.2016 |
All reports are available in the Overview.
cz